Literature DB >> 17213484

Cell-based multiwell assays for the detection of substrate accumulation and oxidation.

A J Wensaas1, A C Rustan, K Lövstedt, B Kull, S Wikström, C A Drevon, S Hallén.   

Abstract

We describe multiwell assays for detecting the accumulation as well as the subsequent oxidation of (14)C-labeled substrates in cultured cells. Accumulation is monitored in real time by an established scintillation proximity assay in which the scintillator is embedded in the plate base primarily detecting cell-associated radiolabel. The substrate oxidation assay is a novel variant of previously described experimental approaches aimed at trapping (14)CO(2) produced by isolated enzymes, organelles, or intact cells. This method uses a standard 96-well tissue culture plate and, on top, an inverted filter plate immersed with NaOH that are clamped into a sandwich sealed with a silicon gasket to obtain gas-tight compartments. (14)CO(2) is captured in the filter and quantified by conventional scintillation. We demonstrate both the accumulation and subsequent oxidation of (14)C-labeled substrates in cultured human myotubes, adipocytes, and hepatocytes. Both methods are adaptable for compound screening; at the same time, these protocols provide easy-to-use and time- saving methods for in vitro studies of cellular fuel handling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213484     DOI: 10.1194/jlr.D600047-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  Naturally occurring R225W mutation of the gene encoding AMP-activated protein kinase (AMPK)gamma(3) results in increased oxidative capacity and glucose uptake in human primary myotubes.

Authors:  S A Crawford; S R Costford; C Aguer; S C Thomas; R A deKemp; J N DaSilva; D Lafontaine; M Kendall; R Dent; R S B Beanlands; R McPherson; M-E Harper
Journal:  Diabetologia       Date:  2010-05-15       Impact factor: 10.122

2.  Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice.

Authors:  C Zhang; C McFarlane; S Lokireddy; S Masuda; X Ge; P D Gluckman; M Sharma; R Kambadur
Journal:  Diabetologia       Date:  2011-09-17       Impact factor: 10.122

Review 3.  In vitro experimental models for examining the skeletal muscle cell biology of exercise: the possibilities, challenges and future developments.

Authors:  Steven Carter; Thomas P J Solomon
Journal:  Pflugers Arch       Date:  2018-10-05       Impact factor: 3.657

4.  Benfotiamine increases glucose oxidation and downregulates NADPH oxidase 4 expression in cultured human myotubes exposed to both normal and high glucose concentrations.

Authors:  D A Fraser; N P Hessvik; N Nikolić; V Aas; K F Hanssen; S K Bøhn; G H Thoresen; A C Rustan
Journal:  Genes Nutr       Date:  2011-10-09       Impact factor: 5.523

5.  Loss of perilipin 2 in cultured myotubes enhances lipolysis and redirects the metabolic energy balance from glucose oxidation towards fatty acid oxidation.

Authors:  Yuan Z Feng; Jenny Lund; Yuchuan Li; Irlin K Knabenes; Siril S Bakke; Eili T Kase; Yun K Lee; Alan R Kimmel; G Hege Thoresen; Arild Christian Rustan; Knut Tomas Dalen
Journal:  J Lipid Res       Date:  2017-08-19       Impact factor: 5.922

6.  Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals.

Authors:  E T Kase; G H Thoresen; S Westerlund; K Højlund; A C Rustan; M Gaster
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122

7.  APOE alters glucose flux through central carbon pathways in astrocytes.

Authors:  Holden C Williams; Brandon C Farmer; Margaret A Piron; Adeline E Walsh; Ronald C Bruntz; Matthew S Gentry; Ramon C Sun; Lance A Johnson
Journal:  Neurobiol Dis       Date:  2020-01-11       Impact factor: 5.996

8.  Metabolic switching of human myotubes is improved by n-3 fatty acids.

Authors:  N P Hessvik; S S Bakke; K Fredriksson; M V Boekschoten; A Fjørkenstad; G Koster; M K Hesselink; S Kersten; E T Kase; A C Rustan; G H Thoresen
Journal:  J Lipid Res       Date:  2010-04-02       Impact factor: 5.922

9.  Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet.

Authors:  Chek Kun Tan; Nicolas Leuenberger; Ming Jie Tan; Yew Wai Yan; Yinghui Chen; Ravi Kambadur; Walter Wahli; Nguan Soon Tan
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

10.  Remodeling of oxidative energy metabolism by galactose improves glucose handling and metabolic switching in human skeletal muscle cells.

Authors:  Eili Tranheim Kase; Nataša Nikolić; Siril Skaret Bakke; Kaja Kamilla Bogen; Vigdis Aas; G Hege Thoresen; Arild Christian Rustan
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.